| |
| |
|
| Insider
Information: |
Chen Jin-Long |
| Relationship: |
Chief Scientific Offic... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
972,893 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,498,255 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
972,893 |
|
|
| Total
Value |
$1,498,255 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ngm Biopharmaceuticals Inc |
NGM |
Chief Scientific Offic... |
2023-03-02 |
972,893 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific OfficerOffice |
• • – |
2019-04-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
924,943 |
|
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
64,000 |
972,893 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2019-11-01 |
4 |
OE |
$0.52 |
$53,730 |
D/D |
83,153 |
996,693 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-01-08 |
4 |
OE |
$0.52 |
$60,399 |
D/D |
87,784 |
1,068,443 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-01-05 |
4 |
OE |
$0.60 |
$90,000 |
D/D |
150,000 |
1,020,005 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2019-10-31 |
4 |
OE |
$1.44 |
$40,861 |
D/D |
28,376 |
953,319 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2019-11-04 |
4 |
OE |
$1.44 |
$15,820 |
D/D |
10,986 |
1,007,679 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-01-07 |
4 |
OE |
$1.44 |
$23,170 |
D/D |
16,090 |
1,012,783 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-01-09 |
4 |
OE |
$1.44 |
$26,843 |
D/D |
18,641 |
1,087,084 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-06-03 |
4 |
OE |
$1.44 |
$99,999 |
D/D |
69,444 |
989,449 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-12-06 |
4 |
OE |
$1.44 |
$99,999 |
D/D |
69,444 |
923,893 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2023-01-17 |
4 |
OE |
$1.44 |
$122,518 |
D/D |
85,082 |
993,975 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2023-01-17 |
4 |
S |
$5.15 |
$438,308 |
D/D |
(85,082) |
908,893 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2019-11-04 |
4 |
S |
$12.26 |
$134,694 |
D/D |
(10,986) |
996,693 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2019-10-31 |
4 |
S |
$12.99 |
$368,565 |
D/D |
(28,376) |
924,943 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2019-11-01 |
4 |
S |
$13.29 |
$151,524 |
D/D |
(11,403) |
924,943 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-10-12 |
4 |
AS |
$17.02 |
$425,500 |
D/D |
(25,000) |
945,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-09-01 |
4 |
AS |
$17.62 |
$445,829 |
D/D |
(25,000) |
970,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-11-02 |
4 |
AS |
$17.70 |
$442,500 |
D/D |
(25,000) |
920,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-01-09 |
4 |
S |
$17.95 |
$334,608 |
D/D |
(18,641) |
1,068,443 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-01-08 |
4 |
S |
$17.98 |
$288,288 |
D/D |
(16,034) |
996,693 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-01-07 |
4 |
S |
$18.20 |
$292,877 |
D/D |
(16,090) |
996,693 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-12-06 |
4 |
AS |
$18.21 |
$273,150 |
D/D |
(15,000) |
854,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-12-07 |
4 |
AS |
$18.60 |
$279,000 |
D/D |
(15,000) |
908,893 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-07-01 |
4 |
AS |
$18.79 |
$472,728 |
D/D |
(25,000) |
1,020,005 |
0 |
% |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
